Acute Ischemic Stroke Therapeutics Market
According to Intent Market Research, the Acute Ischemic Stroke Therapeutics Market is expected to grow from USD 8.6 billion in 2023 at a CAGR of 5.9% to touch USD 12.8 billion by 2030. The Acute Ischemic Stroke Therapeutics Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Boehringer Ingelheim GmbH, Novo Nordisk A/S, and Eli Lilly and Company.